World Literature on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -27

World Literature on Medicinal Plants from Pankaj Oudhia’s Medicinal Plant Database -27

World Literature on Medicinal Plants Quoted/Consulted/Modified/Improved/Discussed/Used/Corrected in Pankaj Oudhia’s Medicinal Plant Database.

For details please visit http://www.pankajoudhia.com

Krentz, A.J., Bailey, C.J., 2005. Oral antidiabetic agents: current role in type 2

diabetes mellitus. Drugs 65, 385–411.

Lenhard, J.M., Croom, D.K., Minnick, D.T., 2004. Reduced serum dipeptidyl

peptidase-IV after metformin and pioglitazone treatments. Biochem.

Biophys. Res. Commun. 324, 92–97.

Lindsay, J.R., Duffy, N.A., McKillop, A.M., Ardill, J., O'Harte, F.P.M., Flatt, P.R.,

Bell, P.M., 2005. Inhibition of dipeptidyl peptidase IV activity by oral

metformin in type 2 diabetes. Diabet. Med. 22, 654–657.

Mannucci, E., Ognibene, A., Cremasco, F., Bardini, G., Mencucci, A., Pierazzuoli,

E., Ciani, S., Messeri, G., Rotella, C.M., 2001. Effect of metformin on

glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic

subjects. Diabetes Care 24, 489–494.

Mari, A., Gastaldelli, A., Foley, J.E., Pratley, R.E., Ferrannini, E., 2005. Beta-cell

function in mild type 2 diabetic patients: effects of 6-month glucose lowering

with nateglinide. Diabetes Care 28, 1132–1138.

McClenaghan, N.H., Barnett, C.R., Ah-Sing, E., Abdel-Wahab, Y.H., O'Harte,

F.P.M., Yoon, T.W., Swanston-Flatt, S.K., Flatt, P.R., 1996. Characterization

of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11,

produced by electrofusion. Diabetes 45, 1132–1140.

McClenaghan, N.H., Flatt, P.R., Ball, A.J., 2006. GLP-1 augments KATP

channel-dependent and independent effects of glucose, sulphonylureas and

nateglinide. J. Endocrinol. 190, 889–896.

McKillop, A.M., Duffy, N.A., Lindsay, J.R., Green, B.D., O'Harte, F.P.M.,

Bell, P.M., Flatt, P.R., 2006. Insulinotropic actions of nateglinide are

accompanied by inhibition of dipeptidyl peptidase-IV activity. Diabetologia 49 (Suppl 1), 482.

Mentlein, R., 2005. Therapeutic assessment of glucagon-like peptide-1 agonists

compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic

drugs. Expert Opin. Investig. Drugs 14, 57–64.

Ramshur, E.B., Rull, T.R., Wice, B.M., 2002. Novel insulin/GIP co-producing

cells provide unexpected insights into gut K-cell function in vivo. J. Cell.

Physiol. 192, 339-250.

Reimann, F., Gribble, F.M., 2002. Glucose-sensing in glucagon-like peptide-1-

secreting cells. Diabetes 51, 2757–2763.

Stevens, J.F., 1971. Determination of glucose by an automatic analyser. Clin.

Chim. Acta 32, 199–201.

Suga, S., Kanno, T., Ogawa, Y., Takeo, T., Kamimura, N., Wakui, M., 2000.

cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-

1 in rat pancreatic beta-cells. Pflugers Arch. 440, 566–572.

Yasuda, N., Inoue, T., Nagakura, T., Yamazaki, K., Kira, K., Saeki, T., Tanaka,

I., 2002. Enhanced secretion of glucagon-like peptide 1 by biguanide

compounds. Biochem. Biophys. Res. Commun. 298, 779–784.

[1] Umar A, Ahmed QU, Muhammad BY, Dogarai BB, Soad SZ.

Anti-hyperglycemic activity of the leaves of Tetracera scandens

Linn. Merr. (Dilleniaceae) in alloxan induced diabetic rats. J

Ethnopharmacol 2010; 131(1): 140-145.

[2] Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence

of diabetes, estimates for the year 2000 and projections for 2030.

Diabetes Care 2004; 27(5): 1047-1053.

[3] Aslan M, Orhan N, Orhan DD, Ergun F. Hypoglycemic activity and

antioxidant potential of some medicinal plants traditionally used

in Turkey for diabetes. J Ethnopharmacol 2010; 128(2): 384-389.

[4] Chunga IM, Kima EH, Yeoa MA, Kima SJ, Seob MC, Moonc HI.

Antidiabetic effects of three Korean sorghum phenolic extracts

in normal and streptozotocin-induced diabetic rats. Food Res Int

2011; 44(1): 127-132.

[5] Hemalatha S, Wahi AK, Singh PN, Chansouria JPN. Anticonvulsant

and free radical scavenging activity of Hybanthus enneaspermus:

A preliminary screening. Ind J Traditional Knowledge 2003; 2(4):

383-388.

[6] Weniger B, Lagnika L, Vonthron-Sénécheau C, Adjobimey T,

Gbenou J, Moudachirou M, et al. Evaluation of ethnobotanically

selected Benin medicinal plants for their in vitro antiplasmodial

activity. J Ethnopharmacol 2004; 90(2): 279-284.

[7] Das S, Dash SK, Padhy SN. Ethnobotanical information from

Orissa state, India. A Review. J Hum Ecol 2004; 14: 165-227.

[8] Kirtikar KR, Basu BD. Indian medicinal plants. 2nd ed. Delhi:

Periodical Experts Book Agency; 1991.

[9] Tripathy S, Sahoo SP, Pradhan D, Sahoo S, Satapathy DK.

Evaluation of anti arthritic potential of Hybanthus enneaspermus.

Afr J Pharm Pharacol 2009; 3(12): 611-614.

[10] Khandelwal KR. Practical pharmacognosy techniques and

experiments. 17th ed. Pune: Nirali prakashan; 2007, p. 149-156.

[11] Harborne JB. Phytochemical methods. London: Chapman & Hall;

1998.

[12] Zovko Končić M, Kremer D, Gruz J, Strnad M, Biševac G, Kosalec

I, et al. Antioxidant and antimicrobial properties of Moltkia

petraea (Tratt.) Griseb. flower, leaf and stem infusions. Food Chem

Toxicol 2010; 48(6): 1537-1542.

[13] Kumaran A, Karunakaran RJ. Antioxidant and free radical

scavenging activity of an aqueous extract of Coleus aromaticus.

Food Chem 2006; 97(1): 109-114.

[14] Verhagen H, Aruoma OI, Van Delft JH, Dragsted LO, Ferguson

LR, Knasmüller S, et al. The 10 basic requirements for a scientific

paper reporting antioxidant, antimutagenic or anticarcinogenic

potential of test substances in in vitro experiments and animal

studies in vivo. Food Chem Toxicol 2003; 41(5): 603-610.

[15] Shen Q, Zhang B, Xu R, Wang Y, Ding X, Li P. Antioxidant activity

in vitro of the selenium-contained protein from the Se-enriched

Bifidobacterium animalis 01. Anaerobe 2010; 16(4): 380-386.

[16] Ebrahimzadeh MA, Pourmorad F, Hafezi S. Antioxidant activities

of Iranian corn silk. Turk J Biol 2008; 32: 43-49.

[17] Jayaprakasha GK, Jaganmohan RL, Sakariah KK. Antioxidant

activities of flavidin in different in vitro model systems. Bioorg

Med Chem 2004; 12(19): 5141-5146.

[18] Srinivasan R, Chandrasekar MJN, Nanjan MJ, Suresh B.

Antioxidant activity of Caesalpinia digyna root. J Ethnopharmacol

2007; 113(3): 284-291.

[19] Kannan RRR, Arumugam R, Anantharaman P. In vitro antioxidant

activities of ethanol extract from Enhalus acoroides (L.F.) Royle.

Asian Pac J Trop Med 2010; 3(11): 898-901.

[20] Yildirim A, Mavi A, Kara A. Determination of antioxidant and

antimicrobial activities of Rumex crispus L. extracts. J Agricult

Food Chem 2001; 49(8): 4083-4089.

[21] Salahuddin M, Jalalpure SS. Antidiabetic activity of aqueous fruit

extract of Cucumis trigonus Roxb. in streptozotocin-induceddiabetic rats. J Ethnopharmacol 2010; 127(2): 565-567.

[22] Liu H, Liu X, Lee J, Liu Y, Yang H, Wang G, et al. Insulin therapy

restores impaired function and expression of P-glycoprotein in

blood-brain barrier of experimental diabetes. Biochem Pharmacol

2008; 75(8): 1649-1658.

[23] Hemalatha S, Sachdeva N, Wahi AK, Singh PN, Chansouria JPN.

Effect of aqueous extract of fruits of Withania coagulans on

glucose utilization by rat hemidiaphragm. Ind J Nat Prod 2005;

21: 20-21.

[24] Singh SK, Kesari AN, Gupta RK, Jaiswal D, Watal G. Assessment

of antidiabetic potential of Cynodon dactylon extract in

streptozotocin diabetic rats. J Ethnopharmacol 2007; 114(2):

174-179.

[25] Sridhar SB, Sheetal UD, Pai MRSM, Shastri MS. Preclinical

evaluation of the antidiabetic effect of Eugenia jambolana seed

powder in streptozotocindiabetic rats. Braz J Med Biol Res 2005;

38(3): 463-468.

[26] Szkudelski T. The mechanism of alloxan and streptozotocin action

in B cells of the rat pancreas. Physiol Res 2001; 50(6): 537-546.

[27] Imran M, Khan H, Shah M, Khan R, Khan F. Chemical composition

and antioxidant activity of certain Morus species. J Zhejiang

Univ-Sci B (Biomed & Biotechnol) 2010; 11(12): 973-980.

[28] Kumaran A, Karunakaran J. In vitro antioxidant activities of

methanol extracts of 420 five Phyllanthus species from India. LWT

2006; 40: 344-352.

[29] Singha R, Singhb S, Kumarb S, Aroraa S. Evaluation of antioxidant

potential of ethyl acetate extract/fractions of Acacia auriculiformis

A. Cunn. Food Chem Toxicol 2007; 45(7): 1216-1223.

[30] Koncić MZ, Kremer D, Gruz J, Strnad M, Bisevac G, Kosalec I, et

al. Antioxidant and antimicrobial properties of Moltkia petraea

(Tratt.) Griseb. flower, leaf and stem infusions. Food Chem Toxicol

2010; 48(6): 1537-1542.

[31] Halliwell B. Reactive oxygen species in living systems: source,

biochemistry, and role in human disease. Am J Med 1991; 91(3):

14-22.

[32] Nakayama T. Suppression of hydroperoxide-induced cytotoxicity

by polyphenols. Cancer Res 1994; 54(7): 1991-1993.

[33] Chika A, Bello SO. Antihyperglycaemic activity of aqueous leaf

extract of Combretum micranthum (Combretaceae) in normal and

alloxan-induced diabetic rats. J Ethnopharmacol 2010; 129(1):

34-37.

[34] Suba V, Murugesan T, Rao RB, Ghosh L, Pal M, Mandal SC, et

al. Antidiabetic potential of Barleria lupulina extract in rats.

Fitoterapia 2004; 75(1): 1-4.

[35] Gülçin I, Elmastaş M, Aboul-Enein HY. Determination of

antioxidant and radical scavenging activity of basil (Ocimum

basilicum L. Family Lamiaceae) assayed by different

methodologies. Phytother Res 2007; 21(4): 354-361.

[36] Jing LJ, Mohamed M, Rahmat A, Bakar MFA. Phytochemicals,

antioxidant properties and anticancer investigations of the

different parts of several gingers species (Boesenbergia rotunda,

Boesenbergia pulchella var attenuata and Boesenbergia

armeniaca). J Med Plants Res 2010; 4(1): 27-32.

[37] Shukla S, Mehta A, John J, Singh S, Mehta P, Vyas SP. Antioxidant

activity and total phenolic content of ethanolic extract of

Caesalpinia bonducella seeds. Food Chem Toxicol 2009; 47(8):

1848-1851.

[38] Viswanatha GLS, Vaidya SK, Ramesh C, Krishnadas N, Rangappa

S. Antioxidant and antimutagenic activities of bark extract of

Terminalia arjuna. Asian Pac J Trop Med 2010; 3(12): 965-970.

[39] Kumar BSA, Lakshman K, Jayaveera KN, Shekar DS, Kumar AA,

Manoj B. Anitoxidant and antipyretic properties of methanolic

extract of Amaranthus spinosus leaves. Asian Pac J Trop Med

2010; 3(9): 702-706.

BAILEY CJ, NATTRASS M 1998: Non-insulin dependent diabetes mellitus: treatment with metformin. In:

NATTRASS M, HALE PJ: Clinical Endocrinology and Metabolism. Baillière-Tindall, London, pp. 455-476.

DE SMET PA 1997: The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare. Drug 54: 801-840

EVANS JL, GOLDFINE ID, MADDUX BA, GRODSKY GM 2003: Are Oxidative Stress-Activated Signaling

Pathways Mediators of Insulin Resistance and β-Cell Dysfunction? Diabetes 52: 1-8

FEILLET-COUDRAY C, ROCK E, COUDRAY C, GRZELKOWSKA K 1999: Lipid peroxidation and

antioxidant status in experimental diabetes. Clin Chim Acta 284: 31-43.

FUSHIYA S, KISHI Y, HATTORI K, BATKHUU J, TAKANO F, SINGAB AN, OKUYAMA T 1999: Flavonoids

from Cleome droserifolia suppress NO production in activated macrophages in vitro. Planta Med 65: 404-407

GUPTA MP, SOLIS NG, ESPOSITO M, SANCHEZ S 1984: Hypoglycemic activity of Neurolaena lobata (L).

Ethnopharmacology 10: 323-327 

KAKKAR R, MANTHA SV, RADHI J, PRASAD K, KALRA J 1998: Increased oxidative stress in rat liver and

pancreas during progression of streptozotocin-induced diabetes. J Clin Sci 94: 623-632

KOSUGY H, KIKUGAVA K 1989: Potential thiobarbituric acid-reactive substances in peroxidized lipids. Free

Rad Biol Med 7: 205-207

L. AL-SHAMAONY SM, KHAZRAJI AL, TWAIJI HA 1994: Hypoglycaemic effect of Artemnisia herbaalba II.

Effect of a valuable extract on some blood parameters in diabetic animals. Ethnopharmacology 433: 167-171

MELANDER A 1988: Non-insulin dependent diabetes mellitus: treatment with sulphonylureas. In: NATTRASS,

M, HALE, PJ: Clinical Endocrinology and Metabolism. Baillière-Tindall, London, pp. 443-453. 

SANCHEZ-MORENO C, LARRAURI JA, SAURA-CALIXTO F 1998: A procedure to measure the antiradical

efficiency of polyphenols. J Food Sci 76: 270-276

TIWAI AK, MADHUSUDAN RAO J 2002: Diabetes mellitus and multiple therapeutic approaches of

phytochemicals: present status and future prospects. Curr Sci 83: 30-38

ZHANG HY, WANG LF 2002: Theoretical elucidation on structure–antioxidant activity relationships for

indolinonic hydroxylamines. Bioorg Med Chem Lett 12: 225–227

WHO Expert Committee: Diabetes Mellitus. 2nd rep. Geneva, World Health Org., 1980 (Tech. Rep. Ser. 646)

1 National Cancer: Annual cancer statistic review 1973-1988.

bethesda, Department of health and human service 1991,

NIH publication No 91-2789

2 Washaw AL, Fernandez-Del Castillo C. Pancreatic carcinoma.

N Engl J 1992; 326: 455-465

3 Hohne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss

of expression of the potential tumor suppressor gene DCC

in ductal pancreatic adenocarcinoma. Cancer Res 1992; 52:

2616-2619

4 Leszczyniecka M, Roberts T, Dent P, Grant S, Fisher PB.

Differentiation therapy of human cancer: Basic science and

clinical application. Pharmacol ther 2001; 90: 105-156

5 Rosewicz S, Stier U, Brembeck F, Kaiser A, Papadimetriou

CA, Berdel WE, Weidenmann B, Reiken EO. Retinoids: Effect

on growth, differentiation, and nuclear receptor expression in

human pancreatic carcinoma cell lines. Gastroenterology 1995;

109:  1646-1660

6 Rosewicz S, Wollbergs K, Von Lampe B, Matthes H, Kaiser

A, Reiken EO. Retinoids inhibit adhesion to laminin in human

pancreatic carcinoma cells via the α6 β1-integrin receptor.

Gastreoenterology 1997; 112: 532-542

7 Olefsky JM. Treatment of insulin resistance with peroxisomeproliferator-activated receptor γ agonists. J Clin Invest 2000;

106: 467-472

8 Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR alpha, beta and

gamma in adult rats. Endocrinology 1996; 137: 354-366

9 Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer

U, Mangelsdorf DJ, Umesono K, Evans RM. Differential expression and activation of a family of murine peroxisome

proliferator-activated receptors. Pro Natl Acad Sci USA 1994;

91:  7355-7359

10 Roberts-Thomson SJ. Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumor promotion and

treatment. Immunol Cell Biol 2000; 78: 436-441

11 Tontonoz P, Hu E, Spigelman BM. Regulation of adipocyte

gene expression and differentiation by peroxisome proliferatoractivated receptor gamma. Curr Opin Gene Dev 1995; 5: 571-576

12 Tontonoz P, Hu E, Spigelman BM. Stimulation of adipogenesis in fibroblast by PPAR gamma 2, a lipid activated transcription factor. Cell 1994; 79: 1147-1156

13 Reginato MJ, Bailey ST, Krakow SL, Minami C, Ishii S, Tanaka

H, Lazar MA. A potent antidiabetic thiazolidinedione with

unique peroxisome proliferator-activated receptor γ-activating properties. J Biol Chem 1998; 273: 32679-32684

14 Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier

CA, Desvergne B. DNA binding properties of peroxisome

proliferator-activated receptor subtypes on various natural

peroxisome proliferator response elements. J Biol Chem 1997;

272:  25252-25259

15 Pignatelli M, Cortes-Cantelli M, Lai C, Santos A, PerezCastillo A. The peroxisome proliferator-activated receptor γ

is an inhibitor of ErbBs activity in human breast cancer cells.

J Cell Sci 2001; 114(Pt 22): 4117-4126

16 Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW,

Holden S, Miyoshi I, Koeffler HP. Ligand for peroxisome

proliferator-activated receptor γ (Troglitazone) has potent

antotumor effect against human prostate cancer both in vitro

and in vivo. Cancer Res 1998; 58: 3344-3352

17 Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N,

Nagano H, Dono K, Umeshita K, Sakon M, Monden M.

Thiazolidinediones inhibit growth of gastrointestinal, biliary,

and pancreatic adenocarcinoma cells trough activation of the

peroxisome proliferator-activated receptor γ/retinoid X receptor α parhway. Exp Cell Res 2003; 289: 143-151

18 Brockman JA,  Gupta RA, Du Bois RN. Activation of

PPARgamma leads to inhibition of anchorage independent

growth of human colorectal cancer. Gastroenterology 115:

1049-1055

19 Elstner E, Muller C, Koshizuka K, Williamson EA, Park D,

Asou H, Shintaku P, Said JW, Haber D, Koeffler HP. Ligands

for peroxisome proliferator-activated receptor g and retinoid

acid receptor inhibit growth and induce apoptosis of human

breath cancer cells in vitro and in BNX mice. Proc Natl Acad Sci

USA 1998; 95: 8806-8811

20 Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge

JB. Differentiation and reversal of malignant changes in colon

cancer through PPARγ. Nat Med 1998; 4: 1046-1052

21 Kroll TG,  Sarraf P, Pecciarini L, Chen CJ, Mueller E,

Spiegelman B, Fletcher JA. PAX8-PPARγ1 fusion oncogene in

human thyroid carcinoma. Science 2000; 289: 1357-1360

22 Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen

LA. Loss-of-function mutations in PPAR gamma associated

with human colon cancer. Mol Cell 1999; 3: 799-804

23 Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.

Activation of peroxisome proliferator-activated receptor  γ

by troglitazone inhibits cells growth through the increase of

p27 in human pancreatic carcinoma cell. Cancer Res 2000; 60:

5558-5564

24 Kawa S, Nikaido T, Unno H, Usuda N, Nakayama K, Kiyosawa

K. Growth inhibition and differentiation of pancreatic cancer

cell lines by PPARγ ligand troglitazone. Pancreas 2002; 1: 1-7

25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:

680-682

26 Andrews NC, Faller DV. A rapid micropreparation technique

for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res 1991; 19: 2499

27 Invernizzi P, Battezzati PM, Crosignani A, Zermiani P,

Bignotto M, Del Papa N, Zuin M, Podda M. Antibody to

carbonic anhydrase II is present in primary biliary cirrhosis

(PBC) irrespective of antimitochondrial antibody status. Clin

Exp Immunol 1998;  114: 448-454

28 Chomczynski P, Sacchi E. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform

extraction. Anal Biochem 1987; 162: 156-159

29 Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel

AM, Schuppan D, Rotella CM, Surrenti C. Regulation of extracellular matrix synthesis by transforming growth factor β1

in human fat-storing cells. Gastroenterology 1993; 105: 245-253

30 Galli A, Stewart M, Dorris R, Crabb D. High-level expression

of RXRa and the presence of endogenous ligands contribute

to expression of a peroxisome proliferator-activated receptor-responsive gene in hepatoma cells. Ach Biochem Biophys

1998;  358:  288-298

31 Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X,

Vambogelen R, Leff T. Differential activation of peroxisome

proliferator-activated receptor-γ by troglitazone and rosiglitazone.

Diabetes 1999; 49: 539-547

32 de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S.

Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 1987; 7: 725-737

33 Crabb DW, Dixon JE. A method for increasing the sensitivity

of chloramphenicol acetyltransferase assay in extracts of transfected cultured cells. Anal Biochem 1987; 163: 88-92

34 Galli A, Price D, Crabb D. High-level expression of rat class

I alcohol dehydrogenase is sufficient for for ethanol-induced

fat accumulation in transduced HeLa cells. Hepatology 1999;

29:  1164-1170

35 Schussler MH, Skoudy A, Ramaekers FCS, Real FX. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992; 140: 559-568

36 Berge K, Tronstand KJ, Flindt EN, Rasmussen TH, Madsen

L, Kristiansen K, Berge RK. Tetradecylthioacetic acid inhibits

growth of rat glioma cells ex vivo and in vivo via PPARγ-

dependent and PPARγ-independent pathways. Carcinogenesis 2001; 22: 1745-1755

37 Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM,

Halperin JA. Anticancer effects of thiazolidinediones are independent of peroxisome proliferatror-activated receptor  γ

and mediated by inhibition of translation initiation. Cancer Res

2001;  61:  6213-6218

38 Abe A, Kiriyama Y, Hirano M, Miura T, Kamiya H, Harashima

H, Tokumitsu Y. Troglitazone suppresses cell growth of

KU812 cells independently of PPARγ. Eur J Pharmacol 2002;

436:  7-13

39 Inoue I, Katayama S, Takahashi K, Negishi K, Miyazaki T,

Sonoda M, Komoda T. Troglitazone has a scavenging effect

on reactive oxygen species. Biochem Biophys Res Commun 1997;

235:  113-116

40 Zhu L, Gong B, Bisgaier CL, Aviram M, Newton RS. Induction of PPARγ1 expression in human THP-1 monocytic leukemia cells by 9-cis-retinoic acid is associated with cellular growth

suppression. Biochem Biophys Res Commun 1998; 251: 842-848

41 King KL, Cidlowski JA. Cell cycle regulation and apoptosis.

Ann Rev Physiol 1998; 60: 601-617

42 Gao CY, Zelenka PS. Cyclins, cyclin-dependent kinases and

differentiation. BioEssays 1997; 19: 307-315

43 Ungefroren H, Voss M, Jansen M, Henne-Bruns D, Kremer B,

Kalthoff H. Human pancreatic adenocarcinoma express Fas

and Fas ligand yet are resistant to Fas-mediated apoptosis.

Cancer Res 1998; 58: 1741-1749

44 Raitano AB, Scudieri P, Korc M. Binding and biological effect

of tumor necrosis factor and gamma interferon in human

pancreatic carcinoma cell. Pancreas 1990; 5: 267-277

45 Yip-Schneider MT, Sweeney CJ, Jung SH, Crowell PL,

Marshall MS. Cell cycle effect of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination

with gentamicin in pancreatic carcinoma cells. JPET 2001;

298: 976-985

46 Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer

SA. Peroxisome proliferator-activated receptors α and γ are

activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1997; 272: 3406-3410

47 Wick M, Hurteau G, Dessev C, Chan D, Geraci MW, Winn

RA, Heasley LE, Nemenoff RA. Peroxisome proliferator

activated receptor-γ is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Mol Pharmacol 2002; 62:

1207-1214

48 Eibl G,  Wente MN, Reber HA, Hines OJ. Peroxisome

proliferator-activated receptor γ induces pancreatic cancer cell

apoptosis. Biochem Biophys Res Commun 2001; 287: 522-529

49 Li L, Tao J, Davaille J, Feral C, Mallat A, Rieusset J, Vidal H,

Lotersztajn S. 15-deoxy prostaglandin J2 induces apoptosis

of human hepatic myofibroblasts. J Biol Chem 2001;  276:

38152-38158

50 Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. 15-

deoxy-D12-14

-prostaglanding J2-induced apoptosis does not

require PPARg in breast cancer cells. J Lipid Res 2002; 43:

1818-1828

51 Deriny SE,  O’Brien MJ, Christensen TG, Kupchik HZ.

Ultrastructoral differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. Pancreas

1987;  2: 25-33

52 Chang TH, Szabo E. Induction of differentiation and apoptosis

by ligands of peroxisome proliferator-activated receptor-γ in

non-small cell lung cancer. Cancer Res 2000; 60: 1129-1138

1. PANDA S, KAR S (1999) Withania somnifera and

Bauhinia purpurea in the regulation of circulating

thyroid hormone concentrations in female mice. J

Ethnopharmacol 67: 233-239

2. VIANA EP, SANTA-ROSA RS, ALMEIDA SSMS,

SANTOS LS (1999) Constituents of the stem bark of

Bauhinia guianensis. Fitoterapia 70: 111-112

3. SILVA GA, ARAÚJO LCL, OGA S, AKISUE G

(1997) Estudo toxicológico e farmacológico dos

extratos fluídos de Cissus sicyoides L. Rev Bras

Farmacogn 5: 143-155

4. BELTRAME FL, SARTORETTO JL, BAZOTTE RB,

CUMAN RN, CORTEZ DAG (2001): Evaluation of the

antidiabetic potential of Cissus sicyoides L. (Vitaceae).

Quím Nova 24: 783-785

5. PEPATO MT, BAVIERA AM, VENDRAMINI RC,

PÉREZ MPMS, KETTELHUT IC, BRUNETTI IL.

(2003) Cissus sicyoides (princess vine) in the longterm treatment of streptozotocin-diabetic rats.

Biotechnol Appl Biochem 37: 15-20

6. PEPATO MT, KELLER EH, BAVIERA AM,

KETTELHUT IC, VENDRAMINI RC, BRUNETTI

I.L. (2002) Anti-diabetic activity of Bauhinia forficata

decoction in streptozotocin-diabetic rats. J

Ethnopharmacol 81: 191-197

7. WOLFF SP, DEAN RT (1987) Glucose autoxidation

and protein modification. The potential role of

‘autoxidative glycosylation’ in diabetes. Biochem J

245: 243-250

8. BROWNLEE M (2001): Biochemistry and molecular

cell biology of diabetic complications. Nature 414:

813-820

9. COPPEY LJ, GELLETT JS, DAVIDSON EP, YOREK

MA (2003)

.

 Preventing superoxide formation in

epineurial arterioles of the sciatic nerve from diabetic

rats restores endothelium-dependent vasodilation. Free

Radic Res 37: 33-40

10. MARTIN-GALLAN P, CARRASCOSA A, GUSSINYE

M, DOMÍNGUEZ C (2003) Biomarkers of diabetesassociated oxidative stress and antioxidant status in

young diabetic patients with or without subclinical

complications. Free Radic Biol Med 34: 1563 -1574

11. JANBAZ KH, SAEED SA, GILANI AH (2002)

Protective effect of rutin on paracetamol- and CCl4-

induced hepatotoxicity in rodents. Fitoterapia 73: 557-

563

12. PIZZOLATTI MG, CUNHA JA, SZPOGANICZ B, DE

SOUZA E, BRAZ-FILHO R, SCHRIPSEMA J (2003)

Flavonóides Glicosilados das Folhas e Flores de

Bauhinia forficata (Leguminosae) Química Nova 26:

466-469

13. URQUIAGA I, LEIGHTON F (2000) Plant polyphenol

antioxidants and oxidative stress. Biol Res 33: 55-64

14. HALLIWELL B, AESCHBACH R, LÖLIGER J,

ARUOMA OI (1995) The characterization of

antioxidants. Food Chem Toxicol 33: 601-617

15. HAMPTON MB, KETTLE AI, WINTERBOURN CC

(1998) Inside the neutrophil phagosome: oxidants,

myeloperoxidase, and bacterial killing. Blood 92:

3007-3017

16. ZALBA G (2005) NADPH oxidase-mediated oxidative

stress: genetic studies of the p22(phox) gene in

hypertension. Antioxid. Redox Signal 7: 1327-1336

17. HEINECKE JW (1997) Mechanisms of oxidative

damage of low density lipoprotein in human

atherosclerosis. Curr Opin Lipidol 8: 268-274

18. DAUGHERTY A, RATERI DL, DUNN JL,

HEINECKE JW (1994) Myeloperoxidase, a catalyst for

lipoprotein oxidation, is expressed in human

atherosclerotic lesions. J Clin Invest 94: 437-444

19. ZHANG R, BRENNAN ML, FU X, AVILES RJ,

PEARCE GL, PENN MS, TOPOL EJ, SPRECHER DL,

HAZEN SL (2001) Association between

myeloperoxidase levels and risk of coronary artery

disease. JAMA 286: 2136-2142

20. RE R, PELLEGRINI N, PROTEGGENTE A,

PANNALA A, YANG M, RICE-EVANS C (1999)

Antioxidant activity applying an improved ABTS

radical cation decolorization assay. Free Radic Biol

Med 26: 1231-1237

21. KAKKAR P, DAS B, VISWANATHAN PN (1984) A

modified spectrophotometric assay of superoxide

dismutase. Indian J Biochem Biophys 21: 130-132

22. NISHIOKA T, MAKI K, KIMURA M, TAKAHAMA

U (2003) Determination of salivary peroxidase activity

in human mixed whole saliva. Arch Oral Biol 48: 397-

400

23. ARNAO MB, CANO A, ACOSTA M (1999): Methods

to measure the antioxidant activity in plant material. A

comparative discussion. Free Radic Res 31: S89-S96

24. GHISELLI A, SERAFINI M, NATELLA F,

SCACCINI C (2000) Total antioxidant capacity as a

tool to assess redox status: critical view and

experimental data. Free Radic Biol Med 29: 1106-1014

25. JOHNSTON JW, DUSSERT S, GALE S,

NADARAJAN J, HARDING K, BENSON EE (2006)

Optimization of the azinobis-3-ethyl-benzothiazoline-

6-sulphonic acid radical scavenging assay for

physiological studies of total antioxidant activity in

woody plant germplasm. Plant Physiol Biochem 44:

193-201

26. STINEFELT B, LEONARD SS, BLEMINGS KP, SHI

K, KLANDORF H (2005) Free radical scavenging,

DNA protection, and inhibition of lipid peroxidation

mediated by uric acid. Ann Clin Lab Sci 35: 37-45

27. REGASINI LO, VELLOSA JC, SILVA DH, FURLAN

M, DE OLIVEIRA OM, KHALIL NM, BRUNETTI IL,

YOUNG MC, BARREIRO EJ, BOLZANI VS (2008)

Phytochemistry. 69: 1739-44

28. DROGE W (2002) Free radicals in the physiological

control of cell function. Physiol Rev 82: 47-95

29. SABU MC, KUTTAN R (2002) Anti-diabetic activity

of medicinal plants and its relationship with their

antioxidant property. J Ethnopharmacol 81: 155-160

1. Stermitz FR, Lorenz P, Tawara JN, Zenewica LA,

Lewis K. Synergy in a medicinal plant:

antimicrobial action of berberine potentiated by 5’-

methoxyhydrocarpin a multidrug pump inhibitor.

Proc Natl Acad Sci USA 2001;97:1433-1437.

2. Amin AH, Subbaiah TV, Abbasi KM. Berberine

sulfate: antimicrobial activity, bioassay and mode of

action. Can J Microbiol 1969;15:1067-1076.

3. Mahajan, VM, Sharma A, Rattan A. Antimycotic

activity of berberine sulphate: an alkaloid from an

Indian medicinal herb. Sabouraudia 1982;20:79-81.

4. Subbaiah TV, Amin AH. Effect of berberine sulfate

on Entamoeba histolytica. Nature 1967;215:527-528.

5. Gudima SO, Memelova LV, Borodulin VB. Kinetic

analysis of interaction of human immunodeficiency

virus reverse transcriptase with alkaloids. Mol Biol

(Mosk) 1994;28:1308-1314.

6. Singhal KC. Anthelmintic activity of berberine

hydrochloride in trachoma. Indian J Ophthalmol

1982;30:69-75.

7. Mohan M, Pant CR, Angea SK, Mahajan VM.

Berberine in trachoma. Indian J Ophthalmol

1982;30:69-75.

8. Sabir M, Mahajan VM, Mohapatra LN, Bhide NK.

Experimental study of the antitrachoma action of

berberine. Indian J Med Res 1976;64:1160-1167.

9. Taylor CT, Baird AW. Berberine inhibition of

electrogenic ion transport in rat colon. Br J

Pharmacol 1995;116:2667-2672.

10. Akhter MH, Sabir M, Bhide NK. Possible

mechanism of antidiarrhoeal effect of berberine.

Indian J Med Res 1979;70:233-241.

11. Xu Z, Cao HY, Li Q. Protective effects of berberine

on spontaneous ventricular fibrillation in dogs after

myocardial infarction. Chung Kuo Yao Li Hsueh Pao

1989;10:320-324.

12. Ckless K, Schlottfeldt J, Pasqual M. Inhibition of in

vitro lymphocyte transformation by the

isoquinoline alkaloid berberine. J Pharm Pharmacol

1995;47:1029-1031.

13. Wu JF, Liu TP. Effects of berberine in platelet

aggregation and plasma levels of TXb2 and 6-ketoPGF1 alpha in rats with reversible middle cerebral

artery occlusion. Yao Hsueh Hsueh Pao 1995;30:98-

102.

14. Chan MY. The effects of berberine on bilirubin

excretion in the rat. Comp Med East West

1977;5:161-168.

15. Huang W. The role and mechanism of berberine on

coronary arteries. Chung Hua Hsin Hsueh Kuan

Ping Tsa Chih 1990;18:231-234.

16. Hua Z, Wang XL. Inhibitory effect of berberine on

potassium channels in guinea pig ventricular

mycocytes. Acta Pharm Sinica 1994;29:576-580.

17. Hua WG, Song JM, Liao H. Effect of Huang Lian

Su on nerve conduction velocity and hormone level

to diabetic neuropathy in rats. Labeled

Immunoassays & Clin Med 2001;8:212-214.

18. Guo-Yu Pan, Zhi-Jiang Huang, Guang-Ji Wang. The

antihyperglycaemic activity of berberine arises from

a decrease of glucose absorption. Planta Med

2003;69:632-636.

19. Leng SH, Lu F, Xu LJ. Therapeutic effects of

berberine in impaired glucose tolerance rats and its

influence on insulin secretion. Acta Pharmacol

Sinica 2004;25:496-502.

20. Ghosh MN. Toxicity studies. In: Fundamentals of

experimental pharmacology. Calcutta: Scientific

Book Agency, 1984; pp.153-158.

21. Turner MA. In: Screening methods in

pharmacology. New York: Academic Press, 1965;

p.26.

22. Bonner-Weir S, Dery D, John LL, Gordon CW.

Compensatory growth of pancreatic β cells in adult

rats after short-term glucose infusion. Diabetes

1989;38:49-53.

23. Pellegrino M, Broca C, Gross R, Roye M,

Manteghetti M, Hillaire-Buys D.  Development of

a new model of type 2 diabetes in adult rats

administered with streptozotocin and

nicotinamide. Diabetes1998;47:224-229.

24. Nicholas V. The determination of glycogen in liver

and muscle by use of anthrone reagent. Indian J

Biol Chem 1956;220:583-587.

25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid

peroxides in animal tissues by thiobarbituric acid

reaction. Anal Biochem 1979;95:351-358.

26. Brandstrup N, Kirk JE, Bruni C. Determination of

hexokinase in tissues. J Gerontol 1957;12:166-171.

27. Deutsch J. Glucose 6 phosphate dehydrogenase. In:

Bergmeyer Methods of enzymatic analysis, Vol. III,

3

rd

edition. Deerfield Beach, FL: Verlag Chemie,

1983; p. 190.

28. Vassault A. Lactate dehydrogenase. In: Bergmeyer

Methods of enzymatic analysis, Vol. III, 3

rd

edition.

Deerfield Beach, FL: Verlag Chemie, 1983; p. 118.

29. Baginsky ES, Foa PP, Zad B. Glucose 6-

phosphatase. In: Bergmeyer’s Methods in

enzymatic analysis, Vol. 2. New York: Academic

Press, 1974; p. 788-792.

30. Horder M, Rej R. Alanine amino transferase. In:

Bergmeyer Methods of enzymatic analysis, Vol. III,

3

rd

edition. Deerfield Beach, FL: Verlag Chemie,

1983; p. 190.

31. Rotruck JT, Pope AL, Ganther HE, Swanson AB,

Hafeman DG, Hoekstra WG. Selenium

biochemical role as a component of glutathione

peroxide purification and assay. Science

1973;179:588-590.

32. Aebi EH. Catalase. In: Bergmeyer Methods of

enzymatic analysis, Vol. III, 3

rd

edition. Deerfield

Beach, FL: Verlag Chemie, 1983; p. 273.

33. Sinha KA. Colorimetric assay of catalase. Anal

Biochem 1972;47:389-394.

34. Putter J, Becker R. Peroxidase. In: Bergmeyer

Methods of enzymatic analysis, Vol. III, 3

rd

edition.

Deerfield Beach, FL: Verlag Chemie, 1983; p. 286.

35. Kakkar P, Dos B, Viswanathan P.N. A modified

spectrophotometric assay of superoxide dismutase.

Ind J Biochem Biophys 1984;21:130-132.

36. Ravin HA. An improved colorimetric assay of

ceruloplasmin. J Labor Clin Med 1961;589:161-

168.

37. Desai LD. Vitamin E analysis methods for animal

tissues. Methods Enzymol 1984;105:138-142.

38. Omaye ST, Turnball JD, Sauberlich HE. Selected

methods for the determination of ascorbic acid in

animal cells, tissues and fluids. In: McCormick DB,

Wright CD, eds. Methods in enzymology, Vol. 62.

New York: Academic Press, 1979; p. 1-11.

39. Lowry OH, Roesborough MJ, Farr AL, Randall RJ.

Protein measurement with Folin- phenol reagent. J

Biol Chem 1951;193:265-275.

40. Mohamed AK, Bierhaus A, Sciekofer S, Tritschler

H, Ziegler H, Nawroth PP. The role of oxidative

stress and NF (B) activation in late diabetic

complications. Biofactors 1999;10:175-179.

41. Donnini D, Zambito AM, Perella G, AmbesiImpiombat O, Curcio F. Glucose may induce cell

death through a free radical mediated mechanism.

Biochem Biophys Res Commun 1996;219:412-417.

42. Baynes JW, Thorpe SR. Role of oxidative stress in

diabetic complications. Diabetes 1999;48:1-9.

43. Ozturk Y, Altan VM, Yildizoglu A. Effect of

experimental diabetes and insulin on smooth

muscle functions. Pharmacol Rev 1996;48:69-112.

44. Swanston-Flat SK, Day C, Bailey CJ, Flatt PR.

Traditional plant treatments for diabetes: studies

in normal and streptozotocin diabetic mice.

Diabetologia 1990;33:462-464.

45. Chase PH, Glasgow AM. Juvenile diabetes mellitus

and serum lipids and lipoprotein levels. Am J Dis

Child 1976;130:1113.

46. Nikkila EA, Kekki M. Plasma transport kinetics in

diabetes mellitus. Metabolism 1973;22:1-22.

47. Shirwaikar A, Rajendran K, Punitha ISR.

Antidiabetic activity of alcoholic stem extract of C.

fenestratum in streptozotocin nicotinamide induced

type 2 diabetic rats. J Ethnopharmacol

2005;97:369-374.

48. Baquer NZ, Gupta D, Raju J. Regulation of

metabolic pathways in liver and kidney during

experimental diabetes: effects of antidiabetic

compounds. Ind J Clin Biochem 1998;13:63-80.

49. Ugochukwu NH, Babady NE. Antihyperglycaemic

effect of aqueous and ethanolic extract of

Gongronema latifolium levels of glucose and glycogen

metabolism in liver of normal and STZ induced

diabetic rats. Life Sci 2003;73:1924-1938.

50. Burtis CA, Ashwood ER. Carbohydrate metabolism.

In: Tietz textbook of clinical chemistry, 3

rd

edition.

Philadelphia : W.B. Saunders, 1999; p.594-655.

51. Berg JM, Tymoczko JL, Stryer L. Glycolysis and

gluconeogenesis. In: Berg JM, Tymoczko JL, Stryer

L, eds. Biochemistry. New York: W.H. Freeman and

Company, 2001; p. 425-464.

52. Ghosh S, Suryawanshi SA. Effect of  Vinca rosea

extracts in treatment of alloxan diabetes in male

albino rats. Ind J Exp Biol 2001;39:748-759.

53. Felig P, Marliss E, Ohman J, Cahill JF. Plasma amino

acid levels in diabetic ketoacidosis. Diabetes

1970;19:727-730.  

54. Huang X, Vaag A, Hanson M, Weng J, Goop L.

Impaired insulin stimulated expression of the

glycogen synthase gene in skeletal muscle of type 2

diabetic parents is acquired rather than inherited. J

Clin Endocrinol Metab 2000;85:1584-1590.

55. Whitton PP, Hems DA. Glycogen synthesis in

perfused liver of STZ diabetic rats. Biochem J

1975;150:153.

56. Halliwell B, Gutteridge JMC. Free radicals in

biology and medicine. Oxford: Clarendon Press,

1985; p. 1-27.

57. McCord JM, Keele BB, Fridovich I. An enzyme

based theory of obligate anaerobiosis, the

physiological functions of superoxide dismutase.

Proc Natl Acad Sci USA 1976;68:1024-1027.

58. Chance B, Greenstein DS, Roughton RJW. The

mechanism of catalase action – steady state

analysis. Arch Biochem Biophys 1952;37:301-339.

59. Searle AJ, Wilson R. Glutathione peroxide effect of

superoxide, hydroxyl and bromine free radicals on

enzyme activity. Int J Radiat Biol 1980;37:213-217.

60. Meister A. New aspects of glutathione

biochemistry and transport selective alterations of

glutathione metabolism. Nutr Rev 1984;42:397-

410.

61. Nicotera P, Orrenius S. Role of thiols in protection

against biological reactive intermediates. Adv Exp

Med Biol 1986;97:41-49.

62. Anuradha CV, Selvam R. Effect of oral methionine

on tissue lipid peroxidation and antioxidants in

alloxan induced diabetic rats. J Nutr Biochem

1993;4:212-217.

63. Bruce A, Freeman D, James C. Biology of diseasefree radicals and tissue injury. Lab Invest

1982;47:412-426.

64. Matcovis B, Varga SI, Szaluo Witsas H. The effect

of diabetes on the activities of the peroxide

metabolic enzymes. Horm Metab Res 1982;14:77-

79.

65. Kinalski M, Sledziewski A, Telejko B, Zarzycki W,

Kinalska T. Lipid peroxidation and scavenging

enzyme activity in streptozotocin induced

diabetes. Acta Diabetol 2000;37:179-183.

66. Halliwell B, Gutteridge JMC. The antioxidants of

human extracellular fluids. Arch Biochem Biophys

1990;280:1-8.

67. Frei B, England L, Ames BN. Ascorbate is an

outstanding antioxidant in human blood plasma.

Proc Natl Acad Sci USA 1986;86:6377-6381.

68. Inefers H, Sies H. The protection by ascorbate and

glutathione against microsomal lipid peroxidation is

dependent on vitamin E. Eur J Biochem

1988;174:353-357.

69. Sajithlal GB, Chitra P, Chandrakasan G. Effect of

curcumin on the advanced glycation and cross

linking of collagen in diabetic rats. Biochem

Pharmacol 1998;56:1607-1614.

1) World Health Organization., WHO Study Group

of Prevention of Diabetes Mellitus, WHO Tech

Ser, 1994, 844, 11.

2) Siddharth NS., Containing the global epidemic

of diabetes, J. Diabetol., 2001, 3, 11.

3) Holman   R.R,   Turner   R.C.,   Oral   agents   and

insulin in the treatment of NIDDM, In. J. Pickup

and G. Williams, Editors, Text Book of

Diabetes, Blackwell, Oxford, 1991, 467-469.

4) The wealth of India., Publication and

Information directorate (CSIR), New Delhi,

1995, 223-275

5) Satyanarayana T., Sarita T., Balaji M., Ramesh

A., Boini M.K., Anti-hyperglycemic and

hypoglycemic effects of Thespesia Populnea

fruits in normal and all oxan-induced diabetes in

rabbits, Saudi pharmaceutical journal, 2004, 12,

107-111.

6) Sheetal anandjiwala., MS Basnl., M Parabia., M

Rajani., Evaluation of free radical scavenging

activity of an ayurvedic formulation,

Panchvalkala, Indian journal of pharm.sciences,

2008, Nov.91, 70, 31-5

7) Illavarasan R., Vasudevan M., Anbazhagan S.,

Venkataraman S., Antioxidant activity of

Thespesia Populnea bark extracts against carbon

tetrachloride induced liver injury in rats, J.

Ethanopharmacology, 2003, Aug 87 (2-3), 227-

230.

8) Ilavarasan, R., Vasudevan, M., Anbazhagan S.,

Venkataraman S., Sridher, S.K.,

Hepatoprotective activity of Thespesia Populnea

bark extracts against carbon tetrachlorideinduced liver injury in rats, Natural Product

Sciences, 2003; 9, 83-86.

9) Shirwaikar A., Kumar A.V., Krishnanand B.R.,

Sreenivasan K.K., Chemical investigation and

antiheptotoxic activity of Thespesia Populnea,

International journal of Pharmcognosy, 1995, 33,

305-310.

10) Manivasudevan M., Kumar Kishore Gunman,

Milind Parle., Antinociceptive and antiinflammatory effects of Thespesia populnea bark

extract. Journal of ethnopharmacology, 2007,

109, 264-270.

11) Vasudevan M., Parle M., Pharmacological action

of Thespesia Populnea relevant to Alzheimer

disease, Phytomedicine, 2006, Nov., 13 (9-10),

677-87.

12) Akila A., Rani K., Biosynthesis of gossypol in

Thespesia Populnea. Phytochemistry, 1993, 335-

340.

13) Ghosh K., Bhattacharya T.K., Preliminary study

on the anti-implantation activity of compounds

from the extract of seeds of Thespesia Populnea,

Indian Journal of Pharmacology, 2004, 36, 335-

340.

14) Murthy R.S.R., Basu D.K., Murti V.V.S.,

Antifertility activity of (+) gossypol, Current

Sciences, 1981; 50: 64-66.

15) Qian S., Wang Z., Gossypol a potential

antifertility agent for males, Annual review of

pharmacology Toxicological, 1984, 85,329-360.

16) Johnson J.I., Gandhidasan R., Murugesan R.,

Cytotoxicity and superoxide anion generation by

some naturally occurring quinines, Free radical

biology and medicines, 1999, 26, 1072-1078.

17) Daniel M., Medicinal plants-Chemistry and

Properties, Science publishers, 2006, 184.

18) Rastogi RP., Mehrotra BN., Compendium of

indian medicinal Plants, Lucknow, CDRI; and

New Delhi; Publication and information

Directorate; Vol. 5; 1979, 846.

19) Trease GE., Evans WC., Pharmcognosy,

Baillliere Tindall Press, London, 1983, 309-706.

20) Brosky G.,Logothetopoulos. J., Streptozotocin

diabetes in the mouse and guinea pig, Diabetes,

1969, 18: 606-611

21) Babu V., Gangadevi T., Subramanian A.,

Antihyperglycemic effect of Cassia keinii leaf

extract in glucose feed normal rats and alloxam

induced diabetic rats, Indian journal of

pharmacology, 2002, 34, 409-415

22) Murugan P., Leelavinothan., Antioxidant effect

of tetrahydrocurcumin in STZ nicotinamide

induced diabetic rats, Life Science, 2006, 79,

1720-1728.

23) Soon YY., Tan BKH., Singapore Medical

Journal, 2002, 43, 77-85.

1. Chidambara,M. K. ; Jayaprakasha,

G.K.and Singh R.P.(2002):Studies on 

antioxidant activity of pomegranate (Punica

granatum) peel extract using in vivo models

.J. Agric Food Chem 14;50(!7) : 4791

2. Chidambara,M. K. ;Reddy ,V.K.;

Veigas, J.M. and Murthy,U.D. (2004):

Study on   wound healing activity of Punica

granatum peel .J. Med.;7(2):256

3. Dutta, B.k.; Rahman,I and

Das,T.K.(1998) :Antifungal activity of

Indian plant extracts. Mycoses ;41(11-12)

535

4. Gharzouli, K, Khennouf ,S ,Amira S.,

Gharzouli,A (1999): Effects of aqueous

Extracts from quercus ilex L. root bark ,

Punica granatum l.fruit peel and Artemisia

herba asso leaves on ethanol  –induced

gastric damage in rats. Phytother Res;13

(1): 42

5. Goth, M. D. (1985):  Medical

Pharmacology,9

th

Ed. Mosby. Saint Louis

p.471. In contrast to the oral antidiabetic

agents, the exogenous administration of

insulin is well known to produce hypoglycaemia in both normal and alloxan

induced subjects.

6. Gracious,R.R.,Selvasubramanian,S. and

Jayasundar S. (2001): Immunomodulatory

activity of Punica granatum in rabbits  –a

preliminary study.J. Ethnopharma , 78, , l,

85

7. Hallwell,B and Gutteridge,J.(1985):Free

radical in biology and medicine.P.215

8. Kiernan,J.A. (1999): Histological and

histochemical Methods. Theory and

Practice 3

rd

ed P.161.Printed in Great

Britain by the both Press , Somerest.

9. Larner,J.(1985): Insulin and oral

hypocaemic drugs,Glucogon .In: Gilman,

A.O. Goodman ,L, S.,Rall, T.W., Murad,

f.(Eds.).The Pharmacological Basic of

Therapeutics,7

th

Ed. Macmillan, Newyork 

p.1490

10. Machado, T .B.;Leal,I.C.;Claudia,A. 

and Amaral,F.(2002): Antimicrobial

Ellagitannin of Punica granatum fruits:

J.Braz.Chem.Soc.V.13 No.5

11. Mavhjanav,S.M.;Islambekov,S.Y.;Karim

dzhanav,A.L.Ismailov,A.L.(1997):Polyph

enols of pomegranate peels show marked

antitumoer and antiviral action Khim Prir

Soedin, 33:124

12. Morsy, T.A.; Mazyad, S.A. and ElSharkawy(1998): The larvicidal activity of

solvent extracts of three medicinal plants 

against third instar larvae of chrysomyia

albiceps. J. Egypt Soc.Parasitol ; 28(3):699

13. Navarro, V. ; Villarreal, M .l. ; Rojas, G

and Lozoya, X.(1996):  Antimicrobial

Evaluation of  some plants used in Mexican

traditional medicine for the treatment of

infectious diseases .J. Ethnopharma.; 53

(3):143

14. Nogueira,D.G.,Pereira,N.A.,(1984):Activi

ty of Punica grantum L.extract in

Hyperglycemic mice treated with

propranolol. Rev. Bras. Farm.65,46

15. Nogueira,D.G.,Pereira,N.A.,(1986a):Effe

ct of an alcoholic extract from the pericarp

of roma (Punica grantum L.) on insulin

hypoglycaemia mice. Rev. Bras. 

Farm.67,59

16. Nogueira,D.G.,Pereira,N.A.,(1986b):Inhi

bitory action of intestinal absorption of

glucose  of the pericarp  of roma (Punica

grantum L.) Rev. Bras. Farm.67,129

17. Nozire ,O. and Serpil,D.(1993): Valuation

of the pomegranate (Punica granatumL.)

peels from the stand point of pharmacy

.Ankara Ecz.Fak.Derg.,22(1-2),21

18. Paget, G. E. and Barnes, J.M.(1964):"In

toxicity tests" Vol.(1). Chapter (6) P.135,

Editor: Laurance, D.R. and A. L. Academic

Press, London, New York.

19. Prashanth ,D.; Asha,M.K. and Amit,

A.(2001):  Antibacterial activity of Punica

granatum . Fitoterapia;72(2):171

20. Sendecor, G.W. and Coebram,

W.C.,(1969):In "statistical Methods "6

th

ed

Iowa State Univ. Press Anes, Iowa, U. S.A.

P.70

21. Trinder,P.(1969): Determination of

glucose in blood using glucose oxidase with

an alternative acceptor .Ann. of

Clinc.Biochem.6,24

22. Van-Elswijk,D.A., Schobel, U.P. Lansky,

E.p. Irth ,H.and Van-der- Greef

,G.(2004): Rapid dereplication of estrogen

compounds in Punica granatum using online biochemical detection coupled to mass

spectrometry. Phytochemistry;65(2):233

23. Zafar, R. and Singh, J.,(1990):

Antidiabetic activity of Punica granatum

Linn. Sci.Culture 56(7), 3.

24. Zhang, J.; Zhan, B., Yao,X. Gao,Y. and

Shong J. (!995): Antiviral activity of 

tannin from the pericarp of Punica

granatum L. against genital Herpes virus in

vitro .Zhongguo Zhong Yao Za Zhi;20(9)

556.

1) Kiho T., Morimoto H., Sakushima M., Usui S., Ukai S., Biol. Pharm.

Bull., 18, 1627—1629 (1995).

2) Kiho T., Morimoto H., Kobayashi T., Usui S., Ukai S., Aizawa K.,

Inakuma T., Biosci. Biotech. Biochem., 62, 417—419 (2000).

3) Björndall H., Hellerqvist C. G., Lindberg B., Svensson S.,  Angew.

Chem. Int., Ed. Engl., 9, 610—619 (1970).

4) Gorin P. A. J., Barreto-Bergter E., Travassos L. R., Carbohydr. Res.,

95, 205—218 (1981).

5) Kogan G., Pavliak V., Masler L.,  Carbohydr. Res.,  172, 243—253(1988).

6) Bacon B. E., Cherniak R., Kwon-Cheng K. J., Jacobson E. S., Carbohydr. Res., 283, 95—110 (1996).

7) a) Ukai S., Hirose K., Kiho T., Hara C.,  Chem. Pharm. Bull.,  25,

338—344 (1977); Ukai S., Kiho T., Hara C.,  ibid.,  26, 3871—3876

(1978).  b) Gao Q., Seljelid R., Chen H., Jiang R., Carbohydr. Res.,

288, 135—142 (1996).

8) Ukai S., Morisaki S., Goto M., Kiho T., Hara C., Hirose K., Chem.

Pharm. Bull., 30, 635—643 (1982); Sone Y., Kakuta M., Misaki A.,

Agric. Biol. Chem., 42, 417—425 (1978).

9) Fraser C. G., Jennings H. J., Moyna P., Can. J. Biochem., 51, 219—224

(1973).

10) Taylor R. L., Shively J. E., Conrad H. E., Methods Carbohydr. Chem.,

VII, 149—151 (1976).

11) Kiho T., Tsujimura Y., Sakushima M., Usui S., Ukai S.,  Yakugaku

Zasshi, 114, 308—315 (1994).

12) Kiho T., Ito M., Nagai K., Hara C., Ukai S., Chem. Pharm. Bull., 37,

2770—2772 (1989).

13) Kiho T., Itahashi S., Sakushima M., Matsunaga T., Usui S., Ukai S.,

Mori H., Sakamoto Y., Ishiguro Y., Biol. Pharm. Bull., 20, 118—121

(1997).

14) Yasuno S., Murata T., Kokubo K., Yamaguchi T., Kamei M., Biosci.

Biotech. Biochem.,  61, 1944—1946 (1997); Yasuno S., Kokubo K.,

Kamei M., ibid., 63, 1353—1359 (1999).

(Contd.)